Annual report
9220.TEDINET S100RAW5
Period2022-04-01 → 2023-03-31
Filed2023-06-30
StandardJapan GAAP
ConsolidatedYes
Data checks24 of 24 passed
Key figures · 130
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥9.6bn | 2022-04-01 → 2023-03-31 | Cons. | Net sales |
| Revenue | ¥9.2bn | 2021-04-01 → 2022-03-31 | Cons. | Net sales |
| Revenue | ¥9.4bn | 2020-04-01 → 2021-03-31d | Cons. | Net sales (5-year summary) |
| Revenue | ¥9.0bn | 2019-04-01 → 2020-03-31d | Cons. | Net sales (5-year summary) |
| Operating income | ¥544m | 2022-04-01 → 2023-03-31 | Cons. | Operating income |
| Operating income | ¥650m | 2021-04-01 → 2022-03-31 | Cons. | Operating income |
| Ordinary income | ¥737m | 2022-04-01 → 2023-03-31 | Cons. | Ordinary income |
| Ordinary income | ¥648m | 2021-04-01 → 2022-03-31 | Cons. | Ordinary income |
| Ordinary income | ¥608m | 2020-04-01 → 2021-03-31d | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥532m | 2019-04-01 → 2020-03-31d | Cons. | Ordinary income loss (5-year summary) |
| Profit before tax | ¥696m | 2022-04-01 → 2023-03-31 | Cons. | Income before income taxes |
| Profit before tax | ¥710m | 2021-04-01 → 2022-03-31 | Cons. | Income before income taxes |
| Net income (owners) | ¥445m | 2022-04-01 → 2023-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥529m | 2021-04-01 → 2022-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥477m | 2020-04-01 → 2021-03-31d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥486m | 2019-04-01 → 2020-03-31d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income | ¥445m | 2022-04-01 → 2023-03-31 | Cons. | Profit loss |
| Net income | ¥529m | 2021-04-01 → 2022-03-31 | Cons. | Profit loss |
| Total assets | ¥9.0bn | at 2023-03-31 | Cons. | Assets |
| Total assets | ¥7.7bn | at 2022-03-31 | Cons. | Assets |
| Total assets | ¥8.3bn | at 2021-03-31d | Cons. | Total assets (5-year summary) |
| Total assets | ¥8.0bn | at 2020-03-31d | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥6.0bn | at 2023-03-31 | Cons. | Liabilities |
| Total liabilities | ¥5.7bn | at 2022-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥3.0bn | at 2023-03-31 | Cons. | Net assets |
| Net assets / equity | ¥2.0bn | at 2022-03-31 | Cons. | Net assets |
| Net assets / equity | ¥1.5bn | at 2021-03-31d | Cons. | Net assets |
| Net assets / equity | ¥632m | at 2020-03-31d | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥2.4bn | at 2023-03-31 | Cons. | Cash and deposits |
| Cash and deposits | ¥1.8bn | at 2022-03-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥2.2bn | at 2023-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥1.6bn | at 2022-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥1.7bn | at 2021-03-31d | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥976m | at 2020-03-31d | Cons. | Cash and cash equivalents (5-year summary) |
| Operating cash flow | ¥970m | 2022-04-01 → 2023-03-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥899m | 2021-04-01 → 2022-03-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥1.2bn | 2020-04-01 → 2021-03-31d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥847m | 2019-04-01 → 2020-03-31d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Investing cash flow | −¥849m | 2022-04-01 → 2023-03-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥97m | 2021-04-01 → 2022-03-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥112m | 2020-04-01 → 2021-03-31d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥130m | 2019-04-01 → 2020-03-31d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Financing cash flow | ¥464m | 2022-04-01 → 2023-03-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥879m | 2021-04-01 → 2022-03-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥374m | 2020-04-01 → 2021-03-31d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥370m | 2019-04-01 → 2020-03-31d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| EPS (basic) | ¥167.39 | 2022-04-01 → 2023-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥240.32 | 2021-04-01 → 2022-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥238.53 | 2020-04-01 → 2021-03-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥242.76 | 2019-04-01 → 2020-03-31d | Cons. | Basic earnings loss per share (5-year summary) |
| Net assets per share | ¥1,135.13 | at 2023-03-31 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥913.16 | at 2022-03-31 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥673.99 | at 2021-03-31d | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥313.17 | at 2020-03-31d | Cons. | Net assets per share (5-year summary) |
| Equity ratio | 33.7% | at 2023-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 26.1% | at 2022-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 17.8% | at 2021-03-31d | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 7.9% | at 2020-03-31d | Cons. | Equity to asset ratio (5-year summary) |
| ROE | 17.6% | 2022-04-01 → 2023-03-31 | Cons. | Rate of return on equity (5-year summary) |
| ROE | 30.3% | 2021-04-01 → 2022-03-31 | Cons. | Rate of return on equity (5-year summary) |
| ROE | 45.3% | 2020-04-01 → 2021-03-31d | Cons. | Rate of return on equity (5-year summary) |
| ROE | 76.8% | 2019-04-01 → 2020-03-31d | Cons. | Rate of return on equity (5-year summary) |
| Employees | 1,011 | at 2023-03-31 | Cons. | Number of employees |
| Employees | 985 | at 2022-03-31 | Cons. | Number of employees |
| Employees | 999 | at 2021-03-31d | Cons. | Number of employees |
| Employees | 1,051 | at 2020-03-31d | Cons. | Number of employees |
| Revenue | ¥9.3bn | 2022-04-01 → 2023-03-31 | Standalone | Net sales |
| Revenue | ¥8.8bn | 2021-04-01 → 2022-03-31 | Standalone | Net sales |
| Revenue | ¥8.1bn | 2020-04-01 → 2021-03-31d | Standalone | Net sales (5-year summary) |
| Revenue | ¥7.6bn | 2019-04-01 → 2020-03-31d | Standalone | Net sales (5-year summary) |
| Revenue | ¥7.1bn | 2018-04-01 → 2019-03-31d | Standalone | Net sales (5-year summary) |
| Operating income | ¥523m | 2022-04-01 → 2023-03-31 | Standalone | Operating income |
| Operating income | ¥581m | 2021-04-01 → 2022-03-31 | Standalone | Operating income |
| Ordinary income | ¥713m | 2022-04-01 → 2023-03-31 | Standalone | Ordinary income |
| Ordinary income | ¥578m | 2021-04-01 → 2022-03-31 | Standalone | Ordinary income |
| Ordinary income | ¥546m | 2020-04-01 → 2021-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥581m | 2019-04-01 → 2020-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥420m | 2018-04-01 → 2019-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Profit before tax | ¥705m | 2022-04-01 → 2023-03-31 | Standalone | Income before income taxes |
| Profit before tax | ¥548m | 2021-04-01 → 2022-03-31 | Standalone | Income before income taxes |
| Net income | ¥461m | 2022-04-01 → 2023-03-31 | Standalone | Profit loss |
| Net income | ¥368m | 2021-04-01 → 2022-03-31 | Standalone | Profit loss |
| Net income | ¥502m | 2020-04-01 → 2021-03-31d | Standalone | Net income loss (5-year summary) |
| Net income | ¥495m | 2019-04-01 → 2020-03-31d | Standalone | Net income loss (5-year summary) |
| Net income | ¥236m | 2018-04-01 → 2019-03-31d | Standalone | Net income loss (5-year summary) |
| Total assets | ¥8.9bn | at 2023-03-31 | Standalone | Assets |
| Total assets | ¥7.5bn | at 2022-03-31 | Standalone | Assets |
| Total assets | ¥7.8bn | at 2021-03-31d | Standalone | Total assets (5-year summary) |
| Total assets | ¥7.2bn | at 2020-03-31d | Standalone | Total assets (5-year summary) |
| Total assets | ¥7.3bn | at 2019-03-31d | Standalone | Total assets (5-year summary) |
| Total liabilities | ¥5.9bn | at 2023-03-31 | Standalone | Liabilities |
| Total liabilities | ¥5.6bn | at 2022-03-31 | Standalone | Liabilities |
| Net assets / equity | ¥2.9bn | at 2023-03-31 | Standalone | Net assets |
| Net assets / equity | ¥1.9bn | at 2022-03-31 | Standalone | Net assets |
| Net assets / equity | ¥1.5bn | at 2021-03-31d | Standalone | Net assets |
| Net assets / equity | ¥663m | at 2020-03-31d | Standalone | Net assets (5-year summary) |
| Net assets / equity | ¥688m | at 2019-03-31d | Standalone | Net assets (5-year summary) |
| Cash and deposits | ¥2.2bn | at 2023-03-31 | Standalone | Cash and deposits |
| Cash and deposits | ¥1.6bn | at 2022-03-31 | Standalone | Cash and deposits |
| EPS (basic) | ¥173.29 | 2022-04-01 → 2023-03-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥167.07 | 2021-04-01 → 2022-03-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥250.97 | 2020-04-01 → 2021-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥247.56 | 2019-04-01 → 2020-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥1,180,342.28 | 2018-04-01 → 2019-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| Dividend per share | ¥33 | 2022-04-01 → 2023-03-31 | Standalone | Dividend paid per share (5-year summary) |
| Net assets per share | ¥1,097.79 | at 2023-03-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥860.61 | at 2022-03-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥694.69 | at 2021-03-31d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥331.59 | at 2020-03-31d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥3,441,562.86 | at 2019-03-31d | Standalone | Net assets per share (5-year summary) |
| Equity ratio | 33.2% | at 2023-03-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 25.2% | at 2022-03-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 19.5% | at 2021-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 9.2% | at 2020-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 9.4% | at 2019-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| ROE | 19.1% | 2022-04-01 → 2023-03-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 21.5% | 2021-04-01 → 2022-03-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 45.8% | 2020-04-01 → 2021-03-31d | Standalone | Rate of return on equity (5-year summary) |
| ROE | 73.3% | 2019-04-01 → 2020-03-31d | Standalone | Rate of return on equity (5-year summary) |
| ROE | 41.5% | 2018-04-01 → 2019-03-31d | Standalone | Rate of return on equity (5-year summary) |
| Shares issued | 2,676,000 | at 2023-03-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 2,200,000 | at 2022-03-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 2,200,000 | at 2021-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 200 | at 2020-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 200 | at 2019-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Employees | 952 | at 2023-03-31 | Standalone | Number of employees |
| Employees | 938 | at 2022-03-31 | Standalone | Number of employees |
| Employees | 888 | at 2021-03-31d | Standalone | Number of employees |
| Employees | 840 | at 2020-03-31d | Standalone | Number of employees |
| Employees | 785 | at 2019-03-31d | Standalone | Number of employees |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 44
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | capex | 2022-04-01 → 2023-03-31 | ¥3m |
| Reconciling Itemsreconciling | segment assets | at 2023-03-31 | ¥2.9bn |
| Nursing Care Businessreportable segment | capex | 2022-04-01 → 2023-03-31 | ¥761m |
| Nursing Care Businessreportable segment | depreciation | 2022-04-01 → 2023-03-31 | ¥277m |
| Nursing Care Businessreportable segment | employees | at 2023-03-31 | 645 pure |
| Nursing Care Businessreportable segment | revenue | 2022-04-01 → 2023-03-31 | ¥5.2bn |
| Nursing Care Businessreportable segment | revenue external | 2022-04-01 → 2023-03-31 | ¥5.2bn |
| Nursing Care Businessreportable segment | segment assets | at 2023-03-31 | ¥5.0bn |
| Nursing Care Businessreportable segment | segment profit | 2022-04-01 → 2023-03-31 | ¥197m |
| Nursing Care Equipment Businessreportable segment | capex | 2022-04-01 → 2023-03-31 | ¥14m |
| Nursing Care Equipment Businessreportable segment | depreciation | 2022-04-01 → 2023-03-31 | ¥30m |
| Nursing Care Equipment Businessreportable segment | employees | at 2023-03-31 | 316 pure |
| Nursing Care Equipment Businessreportable segment | revenue | 2022-04-01 → 2023-03-31 | ¥4.4bn |
| Nursing Care Equipment Businessreportable segment | revenue external | 2022-04-01 → 2023-03-31 | ¥4.4bn |
| Nursing Care Equipment Businessreportable segment | segment assets | at 2023-03-31 | ¥1.2bn |
| Nursing Care Equipment Businessreportable segment | segment profit | 2022-04-01 → 2023-03-31 | ¥347m |
| Total Of Reportable Segments And Otherssegment total | capex | 2022-04-01 → 2023-03-31 | ¥775m |
| Total Of Reportable Segments And Otherssegment total | depreciation | 2022-04-01 → 2023-03-31 | ¥307m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2022-04-01 → 2023-03-31 | ¥9.6bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2022-04-01 → 2023-03-31 | ¥9.6bn |
| Total Of Reportable Segments And Otherssegment total | segment assets | at 2023-03-31 | ¥6.2bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2022-04-01 → 2023-03-31 | ¥544m |
| Reconciling Itemsreconciling | capex | 2021-04-01 → 2022-03-31 | ¥6m |
| Reconciling Itemsreconciling | segment assets | at 2022-03-31 | ¥2.2bn |
| Nursing Care Businessreportable segment | capex | 2021-04-01 → 2022-03-31 | ¥59m |
| Nursing Care Businessreportable segment | depreciation | 2021-04-01 → 2022-03-31 | ¥282m |
| Nursing Care Businessreportable segment | revenue | 2021-04-01 → 2022-03-31 | ¥5.1bn |
| Nursing Care Businessreportable segment | revenue external | 2021-04-01 → 2022-03-31 | ¥5.1bn |
| Nursing Care Businessreportable segment | segment assets | at 2022-03-31 | ¥4.3bn |
| Nursing Care Businessreportable segment | segment profit | 2021-04-01 → 2022-03-31 | ¥378m |
| Nursing Care Equipment Businessreportable segment | capex | 2021-04-01 → 2022-03-31 | ¥14m |
| Nursing Care Equipment Businessreportable segment | depreciation | 2021-04-01 → 2022-03-31 | ¥27m |
| Nursing Care Equipment Businessreportable segment | revenue | 2021-04-01 → 2022-03-31 | ¥4.0bn |
| Nursing Care Equipment Businessreportable segment | revenue external | 2021-04-01 → 2022-03-31 | ¥4.0bn |
| Nursing Care Equipment Businessreportable segment | segment assets | at 2022-03-31 | ¥1.1bn |
| Nursing Care Equipment Businessreportable segment | segment profit | 2021-04-01 → 2022-03-31 | ¥272m |
| Total Of Reportable Segments And Otherssegment total | capex | 2021-04-01 → 2022-03-31 | ¥73m |
| Total Of Reportable Segments And Otherssegment total | depreciation | 2021-04-01 → 2022-03-31 | ¥309m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2021-04-01 → 2022-03-31 | ¥9.2bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2021-04-01 → 2022-03-31 | ¥9.2bn |
| Total Of Reportable Segments And Otherssegment total | segment assets | at 2022-03-31 | ¥5.5bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2021-04-01 → 2022-03-31 | ¥650m |
| Nursing Care Businessreportable segment | employees | at 2023-03-31 | 591 pure |
| Nursing Care Equipment Businessreportable segment | employees | at 2023-03-31 | 311 pure |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 1,372
| Item | Context | Value | Unit |
|---|---|---|---|
| Net assets per share (5-year summary) | CurrentYearInstant | 1135.13 | |
| Basic earnings loss per share (5-year summary) | Prior3YearDuration | 242.76 | |
| Basic earnings loss per share (5-year summary) | Prior2YearDuration | 238.53 | |
| Basic earnings loss per share (5-year summary) | Prior1YearDuration | 240.32 | |
| Basic earnings loss per share (5-year summary) | CurrentYearDuration | 167.39 | |
| Diluted earnings per share (5-year summary) | Prior3YearDuration | － | |
| Diluted earnings per share (5-year summary) | Prior2YearDuration | － | |
| Diluted earnings per share (5-year summary) | Prior1YearDuration | － | |
| Diluted earnings per share (5-year summary) | CurrentYearDuration | － | |
| Equity to asset ratio (5-year summary) | Prior3YearInstant | 0.079 | |
| Equity to asset ratio (5-year summary) | Prior2YearInstant | 0.178 | |
| Equity to asset ratio (5-year summary) | Prior1YearInstant | 0.261 | |
| Equity to asset ratio (5-year summary) | CurrentYearInstant | 0.337 | |
| Rate of return on equity (5-year summary) | Prior3YearDuration | 0.768 | |
| Rate of return on equity (5-year summary) | Prior2YearDuration | 0.453 | |
| Rate of return on equity (5-year summary) | Prior1YearDuration | 0.303 | |
| Rate of return on equity (5-year summary) | CurrentYearDuration | 0.176 | |
| Price earnings ratio (5-year summary) | Prior3YearDuration | － | |
| Price earnings ratio (5-year summary) | Prior2YearDuration | － | |
| Price earnings ratio (5-year summary) | Prior1YearDuration | － | |
| Price earnings ratio (5-year summary) | CurrentYearDuration | 7.0 | |
| Net cash provided by used in operating activities (5-year summary) | Prior3YearDuration | 847288000 | JPY |
| Net cash provided by used in operating activities (5-year summary) | Prior2YearDuration | 1180952000 | JPY |
| Net cash provided by used in operating activities (5-year summary) | Prior1YearDuration | 898589000 | JPY |
| Net cash provided by used in operating activities (5-year summary) | CurrentYearDuration | 969838000 | JPY |
| Net cash provided by used in investing activities (5-year summary) | Prior3YearDuration | -130346000 | JPY |
| Net cash provided by used in investing activities (5-year summary) | Prior2YearDuration | -111655000 | JPY |
| Net cash provided by used in investing activities (5-year summary) | Prior1YearDuration | -97012000 | JPY |
| Net cash provided by used in investing activities (5-year summary) | CurrentYearDuration | -849259000 | JPY |
| Net cash provided by used in financing activities (5-year summary) | Prior3YearDuration | -369859000 | JPY |
| Net cash provided by used in financing activities (5-year summary) | Prior2YearDuration | -373661000 | JPY |
| Net cash provided by used in financing activities (5-year summary) | Prior1YearDuration | -878808000 | JPY |
| Net cash provided by used in financing activities (5-year summary) | CurrentYearDuration | 463714000 | JPY |
| Cash and cash equivalents (5-year summary) | Prior3YearInstant | 976362000 | JPY |
| Cash and cash equivalents (5-year summary) | Prior2YearInstant | 1671802000 | JPY |
| Cash and cash equivalents (5-year summary) | Prior1YearInstant | 1594586000 | JPY |
| Cash and cash equivalents (5-year summary) | CurrentYearInstant | 2178822000 | JPY |
| Number of employees | Prior3YearInstant | 1051 | |
| Number of employees | Prior2YearInstant | 999 | |
| Number of employees | Prior1YearInstant | 985 | |
| Number of employees | CurrentYearInstant | 1011 | |
| Average number of temporary workers | Prior3YearInstant | 265 | |
| Average number of temporary workers | Prior2YearInstant | 204 | |
| Average number of temporary workers | Prior1YearInstant | 188 | |
| Average number of temporary workers | CurrentYearInstant | 219 | |
| Net sales (5-year summary) | Prior4YearDuration_NonConsolidatedMember | 7149801000 | JPY |
| Net sales (5-year summary) | Prior3YearDuration_NonConsolidatedMember | 7596951000 | JPY |
| Net sales (5-year summary) | Prior2YearDuration_NonConsolidatedMember | 8135467000 | JPY |
| Net sales (5-year summary) | Prior1YearDuration_NonConsolidatedMember | 8784278000 | JPY |
| Net sales (5-year summary) | CurrentYearDuration_NonConsolidatedMember | 9268314000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 24 of 24 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass |
| balance sheet identity | pass rounding |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |